Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02209389Unknown

OctavaPink for Women With Dense Breast After Negative Mammography

Role: lead

NCT02066259Unknown

OctavaColon Cancer Blood Tests OctavaGold and OctavaSilver - Blood Tests for the Help in Diagnosis of Colon Cancer Clinical Study Protocol

Role: lead

NCT01334437Unknown

Blood Test for Ovarian Cancer Associated Auto Antibodies

Role: lead

NCT02066025Unknown

Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test

Role: lead

NCT01343849Unknown

Blood Test for Breast Cancer Associated Auto Antibodies

Role: lead

All 5 trials loaded